NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 109 filers reported holding NEWLINK GENETICS CORP in Q2 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,300,000 | +46.2% | 513,620 | -8.2% | 0.01% | +50.0% |
| Q3 2019 | $889,000 | +10.0% | 559,378 | +2.4% | 0.00% | 0.0% |
| Q2 2019 | $808,000 | +3.6% | 546,290 | +35.2% | 0.00% | +33.3% |
| Q1 2019 | $780,000 | +59.5% | 404,083 | +25.7% | 0.00% | +50.0% |
| Q4 2018 | $489,000 | -29.2% | 321,504 | +11.2% | 0.00% | -33.3% |
| Q3 2018 | $691,000 | -43.9% | 289,092 | +11.9% | 0.00% | -40.0% |
| Q2 2018 | $1,231,000 | +679.1% | 258,458 | +1227.5% | 0.01% | +400.0% |
| Q4 2017 | $158,000 | +172.4% | 19,470 | +241.6% | 0.00% | – |
| Q3 2017 | $58,000 | -76.8% | 5,700 | -76.6% | 0.00% | -100.0% |
| Q4 2016 | $250,000 | -97.9% | 24,342 | -96.3% | 0.00% | -98.3% |
| Q1 2016 | $11,964,000 | -59.6% | 657,381 | -19.3% | 0.06% | -61.3% |
| Q4 2015 | $29,646,000 | +47.7% | 814,752 | +45.5% | 0.16% | +42.2% |
| Q3 2015 | $20,065,000 | +16.0% | 559,936 | +43.3% | 0.11% | +29.8% |
| Q2 2015 | $17,293,000 | – | 390,612 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |